Amgen Close to Buying Onyx Pharmaceuticals for $125/Share -NY TImes

by Charles Gross, Benzinga Editor
August 24, 2013 6:16 PM | 18 seconds read |
The New York Times is reporting that Amgen AMGN is close to a deal to acquire Onyx Pharmaceuticals ONXX for $125 per share. The deal could be announced on Monday, according to sources. Onyx rejected an offer of $120 per share from Amgen. Onyx Pharmaceuticals closed Friday at $116.96.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsRumorsM&ANY Times
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!